Sourasky Medical Center (Ichilov)
| Израиль | Түркия | Австрия | |
| Бауырдың химиоэмболизациясы | бастап $14,800 | бастап $7,500 | бастап $16,000 |
| Бауырдың радиожиілік абляциясы (БРА бауыр) | бастап $9,500 | бастап $3,500 | бастап $12,000 |
| Бауырды резекциялау | бастап $27,500 | бастап $11,700 | бастап $35,000 |
| Бауыр қатерлі ісігінде резекция | бастап $22,000 | бастап $10,800 | бастап $40,000 |
| Бауыр рагында химиялық терапия | - | бастап $1,800 | - |
Клиника Ассута (Assuta) — Израильдегі ең ірі жеке медициналық орталық. Госпиталь онкология, ортопедия, нейро-, кардиохирургия және бедеулікті емдеуге маманданған. Елдегі барлық операциялардың 13% Ассутада өткізіледі, бұл оны хирургия бойынша жетекші орталық етеді.
Емдеудің сапасы мен қауіпсіздігі үшін аурухана американдық Joint Commission International аккредитациясын алды.
Әр жыл сайын Ассута желісінің дәрігерлері 92 000-нан астам операция, 685 000 диагностикалық процедура және 16 000 ЭКО циклдарын өткізеді.
Доктор Пеллес Шарон Сураски медициналық орталығындағы Асқазан-ішек жолдарының ісіктері институтын басқарады. Ол бауыр метастаздарын емдеудегі жетекші маман болып табылады.
Профессор Меримский Сураски медициналық орталығындағы — Израильдің үздік онкологиялық орталықтарының біріндегі сүйек және жұмсақ тіндер онкологиясы бөлімшесін басқарады.
Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.
He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.
Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.
Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.
She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.
Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.
Israel offers advanced treatments for liver metastases. This includes ex vivo liver resection and selective internal radiation therapy. Specialized centers utilize stereotactic radiosurgery and irreversible electroporation for precision. Multidisciplinary tumor boards at JCI-accredited facilities ensure high success rates for complex cases.
Bookimed Expert Insight: Israeli oncology centers like Sheba and Sourasky report high patient volumes. Sheba serves 1,900,000 patients annually and leads in TIL immunotherapies. This high volume allows surgeons to master rare procedures like robotic oncologic resections. Specialists like Dr. Ido Nachmany pioneered these robotic techniques for better recovery.
Patient Consensus: Patients value the precision of SBRT which can significantly reduce lesions. Many note that advanced therapies like NanoKnife allow for much faster recovery times.
Inoperable liver metastases are treatable in Israel using advanced locoregional and systemic therapies. Leading JCI-accredited centers specialize in tumor destruction and growth control. These methods often aim to convert unresectable tumors into a state where surgical removal eventually becomes a viable option.
Bookimed Expert Insight: Israeli oncology centers like Sourasky and Sheba function as high-volume hubs. Sourasky alone reports a 90% average success rate for oncology treatments. Their specialists often combine local ablation with advanced immunotherapy. This multidisciplinary approach allows them to manage complex cases that surgical-only centers might refuse.
Patient Consensus: Patients note it is important to bring original biopsy slides for review in Israel. They highlight the detailed genomic profiling helps doctors find more effective drug combinations.
Top Israeli hospitals for liver metastases include Sourasky Medical Center, Sheba Medical Center, and Hadassah Medical Center. These JCI-accredited institutions utilize multidisciplinary teams and advanced techniques like SIRT, radiofrequency ablation, and robotic resections. They consistently rank among the world's best for oncology success and surgical volume.
Bookimed Expert Insight: While many choose Tel Aviv for its volume, Sheba Medical Center offers unmatched expertise in robotic-assisted liver surgery. Professor Ido Nachmany and Dr. Yuri Goldes pioneered these procedures in Israel. This technology allows for more precise tumor removal while preserving more healthy liver tissue compared to traditional methods.
Patient Consensus: Patients emphasize that starting with a documentation review saves weeks of time. They also note that having a coordinator helps navigate busy wards and ensures clear communication with medical staff.
International patients can start treatment in Israel within 1 to 5 days of arrival. Prior to travel, clinics provide preliminary care plans within 24 to 72 hours. Medical facilities like Sourasky and Sheba prioritize international cases to bypass local public wait times for urgent oncology care.
Bookimed Expert Insight: Data from Sourasky Medical Center and Sheba Medical Center shows a clear preference for private surgical routes to accelerate care. While Sheba serves over 2 million patients annually, choosing private departments at facilities like Assuta can further reduce administrative wait times by 30%. For complex cases, selecting surgeons like Dr. Menahem Ben-haim, who has over 25 years of experience, ensures the initial consultation and surgical planning happen simultaneously.
Patient Consensus: Patients emphasize that having translated biopsy results and original imaging discs ready can shave days off the process. Many note that treatment for metastatic conditions often starts within 10 days of visa approval when logistics are handled effectively.
A repeat biopsy may not be necessary if Israeli pathologists can verify your original tissue samples. Israeli oncology centers typically require physical glass slides or paraffin blocks for an independent histopathology revision. A written report alone is rarely sufficient for planning complex liver metastasis treatment.
Bookimed Expert Insight: Israeli oncology centers like Sourasky or Sheba prioritize precision. While many patients hope to avoid a new procedure, our data shows a high frequency of histopathology revisions. For liver metastases, surgeons often require specific molecular markers to determine if a patient qualifies for advanced therapies like SIRT or specialized liver resections. Sending your physical slides at least 4 weeks before your flight can save you significant time and hospital stay costs upon arrival.
Patient Consensus: Patients note that even fresh biopsies from highly developed countries are often repeated in Israel to meet local laboratory protocols. Many wish they had known to ship their physical slides via medical courier well before their first consultation to avoid diagnostic delays.